Solez K, Axelsen R A, Benediktsson H, Burdick J F, Cohen A H, Colvin R B, Croker B P, Droz D, Dunnill M S, Halloran P F
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Kidney Int. 1993 Aug;44(2):411-22. doi: 10.1038/ki.1993.259.
A group of renal pathologists, nephrologists, and transplant surgeons met in Banff, Canada on August 2-4, 1991 to develop a schema for international standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection. Development continued after the meeting and the schema was validated by the circulation of sets of slides for scoring by participant pathologists. In this schema intimal arteritis and tubulitis are the principal lesions indicative of acute rejection. Glomerular, interstitial, tubular, and vascular lesions of acute rejection and "chronic rejection" are defined and scored 0 to 3+, to produce an acute and/or chronic numerical coding for each biopsy. Arteriolar hyalinosis (an indication of cyclosporine toxicity) is also scored. Principal diagnostic categories, which can be used with or without the quantitative coding, are: (1) normal, (2) hyperacute rejection, (3) borderline changes, (4) acute rejection (grade I to III), (5) chronic allograft nephropathy ("chronic rejection") (grade I to III), and (6) other. The goal is to devise a schema in which a given biopsy grading would imply a prognosis for a therapeutic response or long-term function. While the clinical implications must be proven through further studies, the development of a standardized schema is a critical first step. This standardized classification should promote international uniformity in reporting of renal allograft pathology, facilitate the performance of multicenter trials of new therapies in renal transplantation, and ultimately lead to improvement in the management and care of renal transplant recipients.
1991年8月2日至4日,一群肾脏病理学家、肾病学家和移植外科医生在加拿大班夫会面,制定了一套用于肾脏同种异体移植排斥反应组织学诊断的命名法和标准的国际标准化方案。会后该方案继续完善,并通过分发幻灯片供参与的病理学家评分来验证。在这个方案中,内膜动脉炎和肾小管炎是急性排斥反应的主要病变。对急性排斥反应和“慢性排斥反应”的肾小球、间质、肾小管和血管病变进行定义并评分为0至3+,以便为每次活检生成急性和/或慢性数字编码。小动脉玻璃样变性(环孢素毒性的一种表现)也进行评分。主要诊断类别可使用或不使用定量编码,包括:(1)正常,(2)超急性排斥反应,(3)临界变化,(4)急性排斥反应(I至III级),(5)慢性同种异体肾病(“慢性排斥反应”)(I至III级),以及(6)其他。目标是设计一种方案,使给定的活检分级能够暗示治疗反应或长期功能的预后。虽然临床意义必须通过进一步研究来证实,但制定标准化方案是关键的第一步。这种标准化分类应促进肾脏同种异体移植病理学报告的国际统一,便于进行肾脏移植新疗法的多中心试验,并最终改善肾脏移植受者的管理和护理。